Business Context and Reporting Period
Company: Gencor Industries, Inc. (NYSE American: GENC)
Filing Type: Form 8-K (Current Report)
Date of Report: June 24, 2025
Subject: Notice of Delisting or Failure to Satisfy a Continued Listing Rule; Transfer of Listing (Item 3.01).
Key Financial Metrics
This filing is a regulatory compliance report and does not contain financial performance data. The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Regulatory Status
- Delinquency Notification: On January 3, 2025, the Company received notice from NYSE Regulation for failing to timely file its Form 10-K for the year ended September 30, 2024, by the December 31, 2024 deadline.
- Extension Granted: On June 24, 2025, the NYSE accepted the Company's request for an extension to regain compliance.
- New Cure Deadline: The Company now has a plan period through August 19, 2025 to submit delinquent reports.
- Required Filings: The Company must file the Form 10-K for the year ended September 30, 2024, and Quarterly Reports on Form 10-Q for the periods ended December 31, 2024, and March 31, 2025.
- Maximum Cure Period: If the Company fails to complete delinquent reports by the maximum 12-month cure period ending December 30, 2025, the NYSE will initiate delisting proceedings.
Outlook, Risks, and Management Commentary
Management Expectations: The Company currently expects to file the Form 10-K within the initial six-month period and the required 10-Qs by the August 19, 2025 New Cure Deadline. However, the Company explicitly states there can be no assurance that these reports will be filed within such periods.
Identified Risks:
- Delisting Risk: Failure to meet milestones or file reports by the deadlines could result in the removal of the Company's common stock from the NYSE American.
- Forward-Looking Uncertainties: Actual results may differ due to customer financial conditions, economic changes, and competitive environments.
- Geopolitical and Trade Risks: Potential supply chain disruptions and higher costs due to U.S. government tariff announcements, the Russia-Ukraine invasion, and conflicts involving Israel, Hamas, and Iran.
Investor Verification Checklist
- Verify the filing status of the Form 10-K for the fiscal year ended September 30, 2024, on the SEC EDGAR database.
- Monitor the Company's progress against the August 19, 2025, deadline for filing the 10-Qs for Q4 2024 and Q1 2025.
- Review the attached Press Release (Exhibit 99.1) for additional details on the extension plan.
- Assess the impact of potential delisting on liquidity and trading venue for GENC stock.